FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Piero Pollesello

Research Profile

Chemicals & Drugs

Phenomena

Magnetic Resonance Spectroscopy

Disorders

Anatomy

Living Beings

Concepts & Ideas

Co-author Network

Publications

TOP 3
Carola Gabriella Tilgmann; Marjo Yliperttula; Arto Annila; Juha Kaivola; Martti Ovaska; Piero Pollesello; Jarmo Pystynen; Eija Tiainen; Jouko Mikael Levijoki
Discovery and structural characterization of a phospholamban-binding cyclic peptide and design of novel inhibitors of phospholamban.
Carlo Lucioni; Silvo Mazzi; Piero Pollesello; Marjo Apajasalo; Alessandra D'Ambrosi; Francesco Fedele
Economic evaluation of levosimendan versus dobutamine for the treatment of acute heart failure in Italy.
Matti Kivikko; Wilson S Colucci; Markku S Nieminen; Pasi Pohjanjousi; Piero Pollesello; John R Teerlink; Alexandre Mebazaa
The clinical effects of levosimendan are not attenuated by sulfonylureas.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Piero Pollesello (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Carola Gabriella Tilgmann; Marjo Yliperttula; Arto Annila; Juha Kaivola; Martti Ovaska; Piero Pollesello; Jarmo Pystynen; Eija Tiainen; Jouko Mikael Levijoki
Discovery and structural characterization of a phospholamban-binding cyclic peptide and design of novel inhibitors of phospholamban.
Chemical biology & drug design 2013;81(4):463-73.
2012: Carlo Lucioni; Silvo Mazzi; Piero Pollesello; Marjo Apajasalo; Alessandra D'Ambrosi; Francesco Fedele
Economic evaluation of levosimendan versus dobutamine for the treatment of acute heart failure in Italy.
Advances in therapy 2012;29(12):1037-50.
2012: Matti Kivikko; Wilson S Colucci; Markku S Nieminen; Pasi Pohjanjousi; Piero Pollesello; John R Teerlink; Alexandre Mebazaa
The clinical effects of levosimendan are not attenuated by sulfonylureas.
Scandinavian cardiovascular journal : SCJ 2012;46(6):330-8.
2012: Zoltán Papp; John T Parissis; Alexander Parkhomenko; Piero Pollesello; Markku Salmenperä; Robert H G Schwinger; Bernt Gerhard Wikström; Mehmet Birhan Yilmaz; István Ferenc Édes; Sonja Fruhwald; Martín J García González; Elena Grossini; Fabio Guarracino; Kirsten Jörgensen; Matti Kivikko; Giovanni Landoni; Heli Leppikangas; Alexandre Mebazaa; Sven Meyer; Andrea Morelli; Lars Algotsson; Philippe Caimmi; Stefan G De Hert; Gerasimos Filippatos; Ferenc Follath
Levosimendan: Molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan.
International journal of cardiology 2012;159(2):82-7.
2012: Elena Grossini; David Mary; Claudio Molinari; Piero Pollesello; Giovanni Vacca; Guido Valente; Giorgio Bellomo; Philippe Caimmi
Levosimendan protection against kidney ischemia/reperfusion injuries in anesthetized pigs.
The Journal of pharmacology and experimental therapeutics 2012;342(2):376-88.
2012: Nóra Ambrus; Attila Kun; J Gyula Papp; Piero Pollesello; Jenő Szolnoky; András Varró; János Pataricza
Prolonged antispasmodic effect in isolated radial artery graft and pronounced platelet inhibition induced by the inodilator drug, levosimendan.
Basic & clinical pharmacology & toxicology 2012;110(3):269-74.
2010: Véronique Deschodt-Arsac; Guillaume Calmettes; Gérard Raffard; Philippe Massot; Jean-Michel Franconi; Piero Pollesello; Philippe Diolez
Absence of mitochondrial activation during levosimendan inotropic action in perfused paced guinea pig hearts as demonstrated by modular control analysis.
American journal of physiology. Regulatory, integrative and comparative physiology 2010;299(3):R786-92.
2009: Marjut Louhelainen; Saara Merasto; Piet Finckenberg; Erik Vahtola; Petri Kaheinen; H Leskinen; Jouko Mikael Levijoki; Piero Pollesello; Heimo Haikala; Eero Mervaala
Effects of calcium sensitizer OR-1986 on a cardiovascular mortality and myocardial remodelling in hypertensive Dahl/Rapp rats.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2009;60(3):41-7.
2009: Markku S Nieminen; Piero Pollesello; Gusztáv Vajda; Zoltán Papp
Effects of levosimendan on the energy balance: preclinical and clinical evidence.
Journal of cardiovascular pharmacology 2009;53(4):302-10.
2007: Piero Pollesello; Zoltán Papp
The cardioprotective effects of levosimendan: preclinical and clinical evidence.
Journal of cardiovascular pharmacology 2007;50(3):257-63.
2007: Marjut Louhelainen; Erik Vahtola; Petri Kaheinen; H Leskinen; Saara Merasto; Ville Kytö; Piet Finckenberg; W S Colucci; Jouko Mikael Levijoki; Piero Pollesello; Heimo Haikala; Eero Mervaala
Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats.
British journal of pharmacology 2007;150(7):851-61.
2006: István Leprán; Piero Pollesello; Szilvia Vajda; András Varró; Julius Gy Papp
Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model.
Journal of cardiovascular pharmacology 2006;48(4):148-52.
2006: Julius Gy Papp; Piero Pollesello; András Varró; Agnes Végh; Eva Udvary
The effect of levosimendan during long-term amiodarone treatment in dogs.
Basic & clinical pharmacology & toxicology 2006;99(1):27-32.
2006: Nóra Erdei; Zoltán Papp; Piero Pollesello; István Ferenc Édes; Zsolt Bagi
The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles.
British journal of pharmacology 2006;148(5):696-702.
2006: Julius Gy Papp; Piero Pollesello; András Varró; Agnes Végh
Effect of levosimendan and milrinone on regional myocardial ischemia/reperfusion-induced arrhythmias in dogs.
Journal of cardiovascular pharmacology and therapeutics 2006;11(2):129-35.
2006: Joseph Winaver; Elena Ovcharenko; Irit Rubinstein; Konstantin Gurbanov; Piero Pollesello; Bishara Bishara; Aaron Hoffman; Zaid Abassi
Involvement of Rho kinase pathway in the mechanism of renal vasoconstriction and cardiac hypertrophy in rats with experimental heart failure.
American journal of physiology. Heart and circulatory physiology 2006;290(5):H2007-14.
2006: Wen Zhao; Qunying Yuan; Jiang Qian; Jason R Waggoner; Anand Pathak; Guoxiang Chu; Bryan Mitton; Xiaoyin Sun; Jay Jin; Julian C Braz; Harvey S Hahn; Yehia Marreez; Faisal M Syed; Piero Pollesello; Arto Annila; Hong-Sheng Wang; Jo El J Schultz; Jeffery D Molkentin; Stephen B Liggett; Gerald W Dorn; Evangelia G Kranias
The presence of Lys27 instead of Asn27 in human phospholamban promotes sarcoplasmic reticulum Ca2+-ATPase superinhibition and cardiac remodeling.
Circulation 2006;113(7):995-1004.
2006: Petri Kaheinen; Piero Pollesello; Zita Hertelendi; Attila Borbély; Szabolcs Szilagyi; Erkki Nissinen; Heimo Haikala; Zoltán Papp
Positive inotropic effect of levosimendan is correlated to its stereoselective Ca2+-sensitizing effect but not to stereoselective phosphodiesterase inhibition.
Basic & clinical pharmacology & toxicology 2006;98(1):74-8.
2005: Szabolcs Szilagyi; Piero Pollesello; Jouko Mikael Levijoki; Heimo Haikala; Istvan Bak; Arpád Tósaki; Attila Borbély; István Ferenc Édes; Zoltán Papp
Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone.
Journal of cardiovascular pharmacology 2005;46(3):369-76.
2005: Paola Cescutti; Anne Kallioinen; Giuseppe Impallomeni; Renato Toffanin; Piero Pollesello; Matti Leisola; Tero Eerikäinen
Structure of the exopolysaccharide produced by Enterobacter amnigenus.
Carbohydrate research 2005;340(3):439-47.
2005: Zoltán Papp; Kálmán Csapó; Piero Pollesello; Heimo Haikala; István Ferenc Édes
Pharmacological mechanisms contributing to the clinical efficacy of levosimendan.
Cardiovascular drug reviews 2005;23(1):71-98.
2004: Piero Pollesello; Alexandre Mebazaa
ATP-dependent potassium channels as a key target for the treatment of myocardial and vascular dysfunction.
Current opinion in critical care 2004;10(6):436-41.
2004: Tia Sorsa; Piero Pollesello; R John Solaro
The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c.
Molecular and cellular biochemistry 2004;266(1-2):87-107.
2004: Ove Eriksson; Piero Pollesello; Heimo Haikala
Effect of levosimendan on balance between ATP production and consumption in isolated perfused guinea-pig heart before ischemia or after reperfusion.
Journal of cardiovascular pharmacology 2004;44(3):316-21.
2004: Dalia M Kopustinskiene; Piero Pollesello; Nils-Erik L Saris
Potassium-specific effects of levosimendan on heart mitochondria.
Biochemical pharmacology 2004;68(5):807-12.
2004: Marietta Flores-Diaz; Juan-Carlos Higuita; Inger Florin; Tetsuya Okada; Piero Pollesello; Tomas Bergman; Monica Thelestam; Kazutoshi Mori; Alberto Alape-Giron
A cellular UDP-glucose deficiency causes overexpression of glucose/oxygen-regulated proteins independent of the endoplasmic reticulum stress elements.
The Journal of biological chemistry 2004;279(21):21724-31.
2004: Petri Kaheinen; Piero Pollesello; Jouko Mikael Levijoki; Heimo Haikala
Effects of levosimendan and milrinone on oxygen consumption in isolated guinea-pig heart.
Journal of cardiovascular pharmacology 2004;43(4):555-61.
2004: Szabolcs Szilagyi; Piero Pollesello; Jouko Mikael Levijoki; Petri Kaheinen; Heimo Haikala; István Ferenc Édes; Zoltán Papp
The effects of levosimendan and OR-1896 on isolated hearts, myocyte-sized preparations and phosphodiesterase enzymes of the guinea pig.
European journal of pharmacology 2004;486(1):67-74.
2004: Tia Sorsa; Piero Pollesello; Paul R Rosevear; Torbjörn Drakenberg; Ilkka Kilpeläinen
Stereoselective binding of levosimendan to cardiac troponin C causes Ca2+-sensitization.
European journal of pharmacology 2004;486(1):1-8.
2003: T Sorsa; Piero Pollesello; Perttu Permi; Torbjörn Drakenberg; Ilkka Kilpeläinen
Interaction of levosimendan with cardiac troponin C in the presence of cardiac troponin I peptides.
Journal of molecular and cellular cardiology 2003;35(9):1055-61.
2003: Piero Pollesello; Pentti Nore
Complete structure analysis of OR-1746, a complex product of cyclocondensation of arylhydrazomalononitriles containing clusters of protonated and unprotonated nitrogens, by pulsed-field-gradient heteronuclear NMR.
Journal of pharmaceutical and biomedical analysis 2003;31(1):125-31.
2002: Albrecht G Schmidt; Jing Zhai; Andrew N Carr; Michael J Gerst; John N Lorenz; Piero Pollesello; Arto Annila; Brian D Hoit; Evangelia G Kranias
Structural and functional implications of the phospholamban hinge domain: impaired SR Ca2+ uptake as a primary cause of heart failure.
Cardiovascular research 2002;56(2):248-59.
2002: Piero Pollesello; Arto Annila
Structure of the 1-36 N-terminal fragment of human phospholamban phosphorylated at Ser-16 and Thr-17.
Biophysical journal 2002;83(1):484-90.
2001: Dalia M Kopustinskiene; Piero Pollesello; Nils-Erik L Saris
Levosimendan is a mitochondrial K(ATP) channel opener.
European journal of pharmacology 2001;428(3):311-4.
2001: Jouko Mikael Levijoki; Piero Pollesello; Petri Kaheinen; Heimo Haikala
Improved survival with simendan after experimental myocardial infarction in rats.
European journal of pharmacology 2001;419(2-3):243-8.
2001: Petri Kaheinen; Piero Pollesello; Jouko Mikael Levijoki; Heimo Haikala
Levosimendan increases diastolic coronary flow in isolated guinea-pig heart by opening ATP-sensitive potassium channels.
Journal of cardiovascular pharmacology 2001;37(4):367-74.
2001: Timo Sorsa; Sami Heikkinen; MB Abbott; Ekram M Abusamhadneh; Tapio Laakso; Carola Gabriella Tilgmann; Ritva Serimaa; Arto Annila; Paul R Rosevear; Torbjörn Drakenberg; Piero Pollesello; I Kilpelainen
Binding of levosimendan, a calcium sensitizer, to cardiac troponin C.
The Journal of biological chemistry 2001;276(12):9337-43.
2000: Kimmo Pääkkönen; Timo Sorsa; Torbjörn Drakenberg; Piero Pollesello; Carola Gabriella Tilgmann; Perttu Permi; Sami Heikkinen; Ilkka Kilpeläinen; Arto Annila
Conformations of the regulatory domain of cardiac troponin C examined by residual dipolar couplings.
European journal of biochemistry / FEBS 2000;267(22):6665-72.
2000: Heimo Haikala; Piero Pollesello
Calcium sensitivity enhancers.
IDrugs : the investigational drugs journal 2000;3(10):1199-205.
2000: Jouko Mikael Levijoki; Piero Pollesello; J Kaivola; Carola Gabriella Tilgmann; Timo Sorsa; Arto Annila; Ilkka Kilpeläinen; Heimo Haikala
Further evidence for the cardiac troponin C mediated calcium sensitization by levosimendan: structure-response and binding analysis with analogs of levosimendan.
Journal of molecular and cellular cardiology 2000;32(3):479-91.
1999: O Eriksson; Piero Pollesello; E Geimonen
Regulation of total mitochondrial Ca2+ in perfused liver is independent of the permeability transition pore.
The American journal of physiology 1999;276(6 Pt 1):C1297-302.
1999: Piero Pollesello; Arto Annila; M Ovaska
Structure of the 1-36 amino-terminal fragment of human phospholamban by nuclear magnetic resonance and modeling of the phospholamban pentamer.
Biophysical journal 1999;76(4):1784-95.
1999: Paola Cescutti; Renato Toffanin; Piero Pollesello; I W Sutherland
Structural determination of the acidic exopolysaccharide produced by a Pseudomonas sp. strain 1.15.
Carbohydrate research 1999;315(1-2):159-68.
1998: E Fragonas; Piero Pollesello; V Mlinárik; Renato Toffanin; C Grando; C Godeas; Franco Vittur
Sensitivity of chondrocytes of growing cartilage to reactive oxygen species.
Biochimica et biophysica acta 1998;1425(1):103-11.
1998: Kimmo Pääkkönen; Arto Annila; Timo Sorsa; Piero Pollesello; Carola Gabriella Tilgmann; Ilkka Kilpeläinen; P Karisola; Ismo Ulmanen; Torbjörn Drakenberg
Solution structure and main chain dynamics of the regulatory domain (Residues 1-91) of human cardiac troponin C.
The Journal of biological chemistry 1998;273(25):15633-8.
1998: Paola Cescutti; Renato Toffanin; William F Fett; S F Osman; Piero Pollesello; Sergio Paoletti
Structural investigation of the exopolysaccharide produced by Pseudomonas flavescens strain B62--degradation by a fungal cellulase and isolation of the oligosaccharide repeating unit.
European journal of biochemistry / FEBS 1998;251(3):971-9.
1997: Marietta Flores-Díaz; Alberto Alape-Girón; Bengt Persson; Piero Pollesello; Michael Moos; Christoph von Eichel-Streiber; Monica Thelestam; Inger Florin
Cellular UDP-glucose deficiency caused by a single point mutation in the UDP-glucose pyrophosphorylase gene.
The Journal of biological chemistry 1997;272(38):23784-91.
1997: C Ricci; R Longo; E Gioulis; M Bosco; Piero Pollesello; Flora Masutti; Lory Saveria Crocè; Sergio Paoletti; B de Bernard; Claudio Tiribelli; Ludovico Dalla Palma
Noninvasive in vivo quantitative assessment of fat content in human liver.
Journal of hepatology 1997;27(1):108-13.
1997: M Bosco; nicola culeddu; Renato Toffanin; Piero Pollesello
Organic solvent systems for 31P nuclear magnetic resonance analysis of lecithin phospholipids: applications to two-dimensional gradient-enhanced 1H-detected heteronuclear multiple quantum coherence experiments.
Analytical biochemistry 1997;245(1):38-47.
1996: Piero Pollesello; O Eriksson; K Hockerstedt
Analysis of total lipid extracts from human liver by 13C and 1H nuclear magnetic resonance spectroscopy.
Analytical biochemistry 1996;236(1):41-8.
1995: Piero Pollesello; O Eriksson; Franco Vittur; Sergio Paoletti; E Geimonen; Renato Toffanin
Detection and quantitation of phosphorus metabolites in crude tissue extracts by 1H and 31P NMR: use of gradient assisted 1H-31P HMQC experiments, with selective pulses, for the assignment of less abundant metabolites.
NMR in biomedicine 1995;8(5):190-6.
1995: B J Kvam; E Fragonas; A Degrassi; C Kvam; Mária Matulová; Piero Pollesello; F Zanetti; Franco Vittur
Oxygen-derived free radical (ODFR) action on hyaluronan (HA), on two HA ester derivatives, and on the metabolism of articular chondrocytes.
Experimental cell research 1995;218(1):79-86.
1995: R Longo; Piero Pollesello; C Ricci; Flora Masutti; B J Kvam; L Bercich; Lory Saveria Crocè; P Grigolato; Sergio Paoletti; B de Bernard
Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis.
Journal of magnetic resonance imaging : JMRI 1995;5(3):281-5.
1994: Piero Pollesello; M Ovaska; J Kaivola; Carola Gabriella Tilgmann; K Lundström; Nisse Kalkkinen; Ismo Ulmanen; E Nissinen; Jyrki Taskinen
Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study.
The Journal of biological chemistry 1994;269(46):28584-90.
1994: Piero Pollesello; O Eriksson; N E Saris
Changed relation between phosphorylation potential and left ventricular developed pressure in guinea pig hearts during ischemia-reperfusion.
Annals of the New York Academy of Sciences 1994;723():495-502.
1994: O Eriksson; Piero Pollesello; N E Saris
Effect of phenylephrine on the compartmentation of inorganic phosphate in perfused rat liver during gluconeogenesis and urea synthesis: a 31P-n.m.r.-spectroscopic study.
The Biochemical journal 1994;298 ( Pt 1)():17-21.
1994: Franco Vittur; M Grandolfo; E Fragonas; C Godeas; Sergio Paoletti; Piero Pollesello; B J Kvam; Fabio Ruzzier; T Starc; J W Mozrzymas
Energy metabolism, replicative ability, intracellular calcium concentration, and ionic channels of horse articular chondrocytes.
Experimental cell research 1994;210(1):130-6.
1993: Piero Pollesello; Renato Toffanin; O Eriksson; Ilkka Kilpeläinen; P H Hynninen; Sergio Paoletti; N E Saris
Analysis of lipids in crude extracts by 13C nuclear magnetic resonance.
Analytical biochemistry 1993;214(1):238-44.
1993: C Kvam; D Granese; A Flaibani; Piero Pollesello; Sergio Paoletti
Hyaluronan can be protected from free-radical depolymerisation by 2,6-diisopropylphenol, a novel radical scavenger.
Biochemical and biophysical research communications 1993;193(3):927-33.
1993: Piero Pollesello; Flora Masutti; Lory Saveria Crocè; Renato Toffanin; O Eriksson; Sergio Paoletti; K Höckerstedt; Claudio Tiribelli
1H NMR spectroscopic studies of lipid extracts from human fatty liver.
Biochemical and biophysical research communications 1993;192(3):1217-22.
1992: O Eriksson; Piero Pollesello; N E Saris
Inhibition of lipid peroxidation in isolated rat liver mitochondria by the general anaesthetic propofol.
Biochemical pharmacology 1992;44(2):391-3.
1992: B J Kvam; Piero Pollesello; Franco Vittur; Sergio Paoletti
31P NMR studies of resting zone cartilage from growth plate.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 1992;25(2):355-61.
1991: Piero Pollesello; B de Bernard; M Grandolfo; Sergio Paoletti; Franco Vittur; B J Kvam
Energy state of chondrocytes assessed by 31P-NMR studies of preosseous cartilage.
Biochemical and biophysical research communications 1991;180(1):216-22.
1991: Piero Pollesello; O Eriksson; B J Kvam; Sergio Paoletti; N E Saris
1H-NMR studies of lipid extracts of rat liver mitochondria.
Biochemical and biophysical research communications 1991;179(2):904-11.
1990: Piero Pollesello; Paola D'Andrea; Marco Martina; B de Bernard; Franco Vittur
Modification of plasma membrane of differentiating preosseous chondrocytes: evidence for a degradative process in the mechanism of matrix vesicle formation.
Experimental cell research 1990;188(2):214-8.
1989: C Gazzarrini; N Stagni; Piero Pollesello; Paola D'Andrea; B De Bernard
Possible mechanism of inhibition of cartilage alkaline phosphatase by insulin.
Acta diabetologica latina 1989;26(4):321-7.
1986: B de Bernard; P Bianco; E Bonucci; M Costantini; G C Lunazzi; P Martinuzzi; C Modricky; Luigi Moro; E Panfili; Piero Pollesello
Biochemical and immunohistochemical evidence that in cartilage an alkaline phosphatase is a Ca2+-binding glycoprotein.
The Journal of cell biology 1986;103(4):1615-23.